Forensic Biology · Molecular Forensics

Can Molecular Changes After Death Become a Forensic Clock?

Researchers are investigating whether predictable molecular changes after death can provide additional information about the postmortem interval — but substantial validation and standardization challenges remain. Here is what the 2025–2026 literature actually supports.

In this article Introduction What Is the Postmortem Interval? Why Is Time Since Death So Difficult to Estimate? What Happens at the Molecular Level After Death? Could Molecular Changes Become a Forensic Clock? RNA: A Molecular Timestamp? microRNA: A More Stable Signal? DNA Degradation and Time Since Death Proteins: Reading the Breakdown of the Body Metabolomics Lipidomics and Other Signals DNA Methylation and Epigenetic Clocks The Microbial Clock Multi-Omics Can AI Turn Molecular Data Into a PMI Estimate? Why Can't We Build a Molecular Stopwatch? Comparative Snapshot Table Traditional vs Molecular Methods Research vs Reality Could This Work in India? What Would a Future Clock Need? Conclusion FAQs References

Introduction

Ask any investigator what the hardest question at a death scene is, and many will say the same thing: not who, not how, but when. Estimating the postmortem interval (PMI) — the time elapsed since death — has shaped criminal investigations for centuries, yet it remains one of forensic medicine's most stubborn problems. Algor mortis, rigor mortis, livor mortis and entomological succession still anchor casework, but each loses precision within days, and all are vulnerable to environmental swings.

Over the past decade, a different question has taken shape in forensic journals: could the molecular events that continue inside a body after death — RNA breaking down, proteins unfolding, metabolites shifting, bacteria migrating — carry a more precise time signature than the traditional physical signs? Recent reviews describe this as an emerging "molecular clock" concept, and 2025–2026 has produced the densest cluster of literature on the subject to date, including a major review in the International Journal of Legal Medicine and a comprehensive multi-omics review in Forensic Science International. This article works through that literature, area by area, to ask what the evidence actually supports — and what it does not.

What Is the Postmortem Interval?

PMI refers to the time between death and the examination or discovery of a body. It matters legally and investigatively: it can narrow a suspect list, corroborate or contradict witness accounts, or determine whether a death falls within a statute of limitations. Early PMI (hours to a few days) is traditionally estimated from body temperature decline, rigor mortis progression and livor mortis fixation; medium PMI draws on decomposition staging and entomological evidence; late PMI, involving skeletonized or heavily decomposed remains, relies on taphonomic and, increasingly, biochemical methods.

Why Is Time Since Death So Difficult to Estimate?

The core difficulty is that decomposition is not a fixed-rate process. It is shaped by ambient and body temperature, humidity, clothing, burial depth, submersion, insect access, the individual's body composition, cause of death, and even the microbial load a person carried while alive. Two bodies found in visually similar states of decay may have died hours or days apart depending on these variables. Traditional methods were built around visible, physical change — but physical decomposition is itself downstream of a cascade of molecular events. That has motivated researchers to look earlier in the chain, at the molecular level itself, in search of a more consistent signal.

What Happens to the Body at the Molecular Level After Death?

Death halts circulation and oxygen delivery, but it does not instantly halt cellular activity. Cells initially continue some metabolic processes anaerobically before energy stores are exhausted; enzymes that were held in check by cellular compartmentalization are released as membranes break down (autolysis); nucleases degrade RNA and, more slowly, DNA; proteases break down structural and functional proteins; and, once tissue barriers fail, the body's own and the environment's microbial communities begin to colonize and metabolize tissue. Each of these processes has, in principle, a rate — and rate implies the possibility of a clock. The research question is whether that rate is consistent enough, across individuals and environments, to be forensically useful.

Could Molecular Changes Become a Forensic Clock?

The phrase "forensic molecular clock" describes the idea of using one or more of these measurable degradation or succession processes as a quantitative proxy for elapsed time since death. It is best understood not as a single existing device but as a research direction spanning several molecule classes, each at a different stage of validation. As the 2026 review by He and colleagues frames it, gene expression analysis and related molecular techniques have become "a research hotspot" precisely because conventional methods are strongly affected by environmental and individual variation. Whether any of these approaches currently rival, rather than merely supplement, traditional PMI methods is the question the rest of this article tries to answer discipline by discipline.

RNA: Does It Carry a Molecular Timestamp?

RNA, and messenger RNA in particular, degrades relatively quickly after death through the action of endogenous and bacterial ribonucleases, which has made it an obvious candidate for early-PMI estimation. A systematic review of 29 studies on RNA-based PMI estimation found that researchers have repeatedly evaluated "reference genes" — commonly GAPDH, beta-actin, and 18S/28S rRNA — across tissues including brain, muscle, skin and blood, tracking how quickly their signal decays. A more recent 2026 study in the International Journal of Legal Medicine similarly found that RNA yield and purity vary substantially between tissues, that some housekeeping genes long assumed to be stable reference points (GAPDH, ACTB) actually show postmortem instability, and that ribosomal RNA tends to be more degradation-resistant than messenger RNA.

The recurring finding across this literature is that RNA degradation correlates with PMI within a given tissue and temperature condition, but the rate itself shifts with cause of death, ambient temperature, tissue type, and even which reference gene is used for normalization. That variability is why RNA is described as promising rather than routine: the biological mechanism is well understood, but reproducibility across different sample conditions has not yet been demonstrated at a level suitable for standalone forensic use.

microRNA: A More Stable Molecular Signal?

MicroRNAs (miRNAs) are short, non-coding RNA molecules, typically 18–24 nucleotides long, that regulate gene expression rather than coding for protein. Because of their small size and tight protein-binding, several studies report that miRNAs resist degradation for longer than mRNA, which has driven interest in them as postmortem biomarkers. A 2023 systematic review synthesizing miRNA-PMI studies concluded that miRNA shows real potential as a biomarker, largely due to its comparative stability, but also noted that expression levels are affected by tissue source, cause of death, and temperature, and that findings vary considerably between individual miRNA targets. A separate 2024 systematic review reached a similar conclusion: miRNA panels look promising in principle, but the field is still constrained by small sample sizes and inconsistent methodology across studies.

One study conducted on road traffic accident cases — a common real-world PMI scenario in Indian forensic casework — examined miRNA-195, miRNA-206 and miRNA-378 as potential late-PMI markers and reported that these miRNAs showed measurable, PMI-associated changes in Ct values even at extended postmortem intervals of over a week. This kind of applied human-sample study, distinct from animal-model work, is exactly the type of evidence base that still needs to expand before miRNA panels could be considered for routine forensic use.

DNA Degradation and Time Since Death

DNA is more chemically stable than RNA, which is why it survives long enough to be useful for identification in badly decomposed or skeletal remains — but it still fragments progressively after death, through nuclease activity, oxidative damage, and microbial action. A 2025 review notes that DNA quantity and quality vary sharply depending on where a body is recovered: bodies found outdoors or in water tend to retain more measurable DNA than those recovered from burial, and that in addition to elapsed time, degradation is shaped by endogenous nuclease concentration and external bacterial or environmental contamination. The same review highlights emerging work on DNA isolated from costal cartilage as a way to extend PMI estimation into more advanced decomposition, while stressing this still needs further validation.

Nuclear DNA and mitochondrial DNA do not necessarily degrade at the same rate, and the literature does not support treating DNA fragmentation as a precise, standalone chronometer — it is better understood as one input among several, particularly useful for very late PMI where RNA and many proteins have already been lost.

Proteins: Reading the Breakdown of the Body

Postmortem protein degradation (proteolysis) has become one of the more heavily researched molecular PMI avenues, partly because proteins persist longer than RNA and partly because mass spectrometry now allows large numbers of proteins to be screened simultaneously rather than testing single candidates. A 2026 systematic review in the International Journal of Legal Medicine, examining postmortem protein analysis specifically, notes that PMI estimation becomes especially unreliable beyond the first few hours using traditional methods, which is why attention has shifted toward biomolecular, and specifically protein, alterations. Early mass-spectrometry work in skeletal muscle identified proteins such as eEF1A2 and GAPDH as showing consistent postmortem degradation patterns across rat and mouse models, with some validation extending to human autopsy samples via Western blot.

Bone proteomics has emerged as a particularly active subfield for long PMIs: a 2026 systematic review found that specific bone proteins — including collagen, osteocalcin and fetuin-A — show degradation patterns that correlate with elapsed postmortem time, with cortical bone behaving more predictably than trabecular bone, though rates are still shaped by temperature, humidity, soil pH and microbial activity. A separate 2025 review of proteomic approaches to PMI estimation likewise concludes that protein degradation patterns hold promise as biomarkers, while stressing that most published work remains at the discovery or preliminary-validation stage rather than the routine-casework stage.

No single protein has been shown to function as a universal, standalone chronometer for time since death; the evidence instead supports proteins as one strong component within a broader biomarker panel.

Metabolomics: Following the Chemistry of Death

Metabolomics examines the small-molecule byproducts of cellular breakdown and microbial activity — amino acids, lipids, organic acids and related compounds — that accumulate or deplete in predictable directions after death. Reviews describe metabolomics as particularly attractive because metabolic change appears to be one of the most consistent drivers of measurable postmortem chemistry, and because it can be paired with machine learning to model nonlinear relationships between metabolite concentration and elapsed time. A 2025 study using multi-organ metabolomics combined with machine learning modeled PMI estimation under varying ambient temperatures, illustrating both the appeal of the approach — its ability to incorporate environmental covariates directly into a predictive model — and the underlying complexity of doing so reliably.

Even so, metabolomic profiles are sensitive to cause of death, individual metabolic differences, and especially temperature, which the literature repeatedly identifies as the single largest confound across nearly every molecular PMI method.

Lipidomics and Other Molecular Signals

Lipidomics — the study of postmortem lipid breakdown — is a newer and comparatively smaller strand of this research. Reviews of "omics" approaches to PMI group lipidomics alongside proteomics and metabolomics as part of an integrated mass-spectrometry-based strategy, sometimes referred to as the "Forensomics approach," on the reasoning that combining classes of biomolecules with different postmortem stability profiles gives a more complete biological picture than any single class alone. A systematic review of this literature found that of the studies analyzed, the clear majority used proteomic or metabolomic approaches, with only a small minority focused specifically on lipidomics, reflecting how early-stage this particular subfield still is. The evidence base for lipid markers as independent PMI predictors is accordingly thinner than for proteins or metabolites, and lipidomics currently functions more as a complementary layer within multi-omics work than as a standalone method.

DNA Methylation and Epigenetic Clocks

A distinction worth holding onto

Age estimation and postmortem-interval estimation are different questions. DNA methylation is well validated for the first; it is only exploratory for the second.

DNA methylation-based "epigenetic clocks" are well established for one purpose: estimating a living or deceased person's chronological age from tissue samples, based on age-associated methylation patterns at specific CpG sites. This is a genuinely different question from postmortem interval. A proof-of-principle study using buccal swabs from decomposing bodies found that epigenetic age estimation remained reasonably accurate even across different stages of decomposition, failing only in the most severely putrefied, low-DNA-yield cases. That is a finding about estimating how old the person was, not how long they had been dead.

Using methylation to estimate PMI itself is a much newer and less developed idea. Animal-model work, such as a 2026 study using pig carcasses as human decomposition analogs, found that DNA integrity and methylation levels both declined over the postmortem period and used CpG-based modelling to estimate PMI, with results affected by season. A separate systematic review of PMI methods notes that epigenomic approaches to PMI focused specifically on postmortem methylation change "are still in early development," describing them as a promising direction rather than an established one.

The Microbial Clock: Can Bacteria Tell Time?

Perhaps the most conceptually striking idea in this field is the "microbial clock" — the observation that as a body decomposes, its associated bacterial communities shift in a broadly successional, time-ordered way, first dominated by microbes native to the living human microbiome and later by soil- and environment-derived taxa. This theory, often traced to foundational animal-model research from the early 2010s, has driven a wave of studies attempting to formalize microbial succession into a predictive PMI tool.

The evidence here needs careful separation by model type. Much of the strongest successional data comes from animal cadavers — rodents and pigs — used as human analogs, including recent work modeling rupture time and PMI from seasonal mouse cadaver microbiomes. A 2026 systematic review focused specifically on the forensic microbial clock concluded that microorganisms in the "cadaveric island" do succeed in a broadly predictable pattern over time, constituting a potentially useful PMI tool, but explicitly cautioned that routine forensic applicability remains limited by methodological heterogeneity, a lack of standardized protocols, and interpretive complexity, and recommended that postmortem microbiology continue to be used only within a multidisciplinary framework rather than as a standalone determination. Human cadaver research does exist and is growing, but studying postmortem microbial dynamics in real human bodies is inherently constrained by ethical, legal and practical access issues, which is precisely why animal models remain so central to this literature.

Environmental variability compounds the challenge: soil type, climate, indoor versus outdoor placement, and even a person's antibiotic use or gut health while alive can all shift the starting composition of the microbiome that then succeeds after death. The "microbial clock" is a real and actively studied phenomenon, but it is not yet a validated, standardized forensic instrument.

Multi-Omics: Combining Multiple Molecular Clocks

Because no single molecular layer has proven sufficiently precise or reproducible on its own, a growing share of recent literature — including a major 2026 review dedicated entirely to the subject — argues for combining genomics, transcriptomics, epigenomics, proteomics, metabolomics, lipidomics and microbiomics into an integrated multi-omics PMI model. The underlying logic is straightforward: different molecule classes degrade at different rates and are sensitive to different confounders, so combining them could, in principle, average out some of the noise that limits any single-omics approach and extend reliable estimation across a wider PMI range, from the first hours to months or years after death.

This is a genuinely active and fast-moving area, but it remains a research strategy rather than a deployed forensic method. Multi-omics studies still typically use animal models or small human cohorts, require expensive and specialized instrumentation (particularly mass spectrometry), and have not yet been through the kind of large-scale, cross-population validation that would be required before courts or forensic laboratories could rely on them as a stated PMI figure. The literature is consistent in describing multi-omics as a promising integration strategy that needs standardization, not as a currently validated universal PMI test.

Can Artificial Intelligence Turn Molecular Data Into a PMI Estimate?

Machine learning enters this field primarily as a way to make sense of the high-dimensional data multi-omics work generates — hundreds or thousands of measured biomarkers, environmental variables like temperature and humidity, and categorical variables like tissue type or cause of death, none of which have a simple linear relationship with elapsed time. A 2022 systematic review of AI and machine learning applications to PMI estimation, covering both preclinical and clinical studies, found a growing body of work applying these techniques, while also documenting the field's characteristic limitations: reliance on comparatively small datasets, a shortage of external validation using data the model has never seen, and limited testing across different populations and environmental conditions.

This distinction — between biomarker discovery and validated forensic prediction — is central to interpreting AI/ML claims in this space. A model that fits historical animal-model or single-cohort data well is not the same as a model that has been prospectively validated on new, independent human cases across different climates, causes of death, and postmortem conditions. Overfitting is a genuine risk whenever the number of measured variables (proteins, metabolites, microbial taxa) greatly exceeds the number of cases studied, which is common in current omics-based PMI research. Model interpretability is a further open issue: a complex machine learning model may produce an accurate-looking PMI estimate without a clear biological explanation for why, which complicates both scientific validation and courtroom explainability.

Why Can't We Simply Build a Molecular Stopwatch?

Several converging factors explain why, despite two decades of active research, no molecular method has replaced traditional PMI estimation in day-to-day forensic casework.

Temperature

Nearly every review of this literature identifies ambient and body temperature as the single most influential confound across RNA, protein, metabolite, and microbial degradation rates alike. The same molecular change that indicates one elapsed time at 4°C might indicate a very different elapsed time at 30°C.

Environment

Whether a body is indoors, outdoors, submerged, buried, refrigerated or exposed changes moisture, oxygen access, microbial load and insect access, all of which shift degradation kinetics independently of pure elapsed time.

Individual variation

Age, sex, underlying disease, medication use, body composition, and an individual's baseline microbiome can all influence how quickly molecular degradation proceeds after death.

Cause of death

Sepsis, poisoning, prolonged illness, and trauma can each alter baseline molecular and microbial profiles before death even occurs, complicating the assumption that all bodies start from a comparable biological baseline at the moment of death.

Tissue differences

RNA, protein and microbial change proceeds at different rates in muscle, brain, blood, bone and skin, meaning a biomarker validated in one tissue type cannot automatically be assumed to behave the same way in another.

Sampling and laboratory variation

Where and how a sample is taken, and how it is stored, extracted and analyzed, introduces additional variability that is separate from the biology itself.

Model limitations

A large proportion of the strongest, most granular evidence in this field comes from rodent or pig models, used as human decomposition analogs largely because ethical and practical constraints limit large-scale human cadaver studies. Findings from these models cannot automatically be assumed to transfer to humans without direct validation.

Together, these factors explain why researchers describe molecular PMI methods as promising contributors to, rather than replacements for, the traditional forensic toolkit.

Molecular Approaches to PMI: A Comparative Snapshot

Table 1. Candidate molecular approaches, evidence status, and limitations

Molecular Approach	What Changes After Death?	Potential PMI Information	Current Evidence	Major Limitation
RNA (mRNA)	Ribonuclease-driven degradation of messenger RNA and reference genes	Early PMI, hours to days	Multiple systematic reviews; degradation correlates with PMI but rates vary by tissue and gene	Reference gene instability; strong temperature and tissue dependence
microRNA	Slower degradation than mRNA due to small size and protein binding	Early to extended PMI	Systematic reviews describe genuine promise; human road-traffic-accident data available	Conflicting results between specific miRNA targets; small sample sizes
DNA degradation	Progressive fragmentation via nucleases, oxidation, microbial action	Very late PMI, skeletal remains	Established as a contributor; sensitive to recovery environment	Not precise as a standalone chronometer; nuclear vs mitochondrial rates differ
Protein degradation	Proteolysis of structural and functional proteins	Early to mid PMI (muscle); long PMI (bone)	Mass-spectrometry studies identify consistent degrading proteins across species	Few markers validated directly in humans; tissue-specific behaviour
Proteomics (bone)	Collagen, osteocalcin, fetuin-A and related protein decay	Long-term PMI, months to years	Systematic review finds correlated degradation patterns, especially in cortical bone	Strongly affected by soil pH, temperature, microbial activity
Metabolomics	Shifts in amino acids, organic acids and other small molecules	Short to medium PMI	Multi-organ, multi-temperature studies combined with ML	Highly sensitive to cause of death and individual metabolism
Lipidomics	Postmortem lipid breakdown	Under investigation, largely short PMI	Small evidence base, usually paired with proteomics/metabolomics	Comparatively few dedicated studies
DNA methylation	Changes in CpG methylation patterns	Age estimation is validated; PMI estimation is exploratory	Strong evidence for age estimation; early-stage evidence for PMI	Risk of conflating age estimation with PMI estimation
Microbiome	Successional shift from host-associated to environment-associated taxa	Broad PMI ranges in principle	Systematic review finds broadly predictable succession, mainly in animal models	Limited standardization; heavy reliance on animal analogs
Multi-omics	Combination of the above molecular layers	Potentially the widest PMI range	Actively reviewed as a promising integration strategy	Not yet standardized or independently validated at scale

Traditional Methods vs Molecular Methods

Table 2. Where traditional and molecular PMI methods sit in the postmortem timeline

Method	Approximate PMI Context	Advantages	Limitations
Algor mortis	First 24 hours	Simple, fast, widely used	Rapidly loses accuracy; sensitive to ambient temperature
Rigor mortis	Roughly 1–3 days	No equipment required	Affected by temperature, exertion before death, muscle mass
Livor mortis	First hours to about a day	Useful alongside other early signs	Fixation timing varies between individuals
Decomposition staging	Days to weeks	Applicable across a wide visual range	Highly environment-dependent; subjective staging
Forensic entomology	Days to weeks (longer in some contexts)	Well-validated in many regions; strong evidentiary history	Requires insect access to the body; regional/seasonal variation
Biochemical markers	Hours to days	Quantitative	Still influenced by individual and environmental variation
RNA degradation	Hours to days	Mechanistically well understood	Reproducibility across labs and conditions remains limited
Protein degradation	Days (soft tissue) to years (bone)	Can extend into long PMI via bone proteomics	Few markers validated in large human cohorts
Microbiome succession	Potentially broad PMI range	Present regardless of season or habitat, in principle	Standardization and human validation still limited
Multi-omics	Potentially the broadest range	Combines multiple independent signals	Not yet standardized; resource-intensive

No molecular method currently carries a universally agreed, courtroom-ready time window in the way that, for instance, early rigor mortis progression is conventionally referenced — a limitation the literature is explicit about rather than one this article is imposing on it.

Research vs Reality

Research

Multiple studies report that specific RNA reference genes show measurable, time-dependent degradation after death.

Reality

Environmental temperature, tissue type and even which specific gene is chosen as the "stable" reference can each shift the observed degradation curve, which limits direct, standardized forensic application.

Research

microRNA panels have shown associations with PMI in both animal models and applied human casework, including road-traffic-accident cases.

Reality

Results vary meaningfully between different miRNA targets and tissue sources, and the evidence base remains built from relatively small studies that have not yet been harmonized into a validated panel.

Research

Microbial communities succeed in a broadly time-ordered way as a body decomposes, a pattern popularized as the "microbial clock."

Reality

Much of this evidence comes from animal cadaver models used as human analogs, and human microbiome variation plus environmental unpredictability complicate any claim of a universal succession timeline.

Research

Multi-omics approaches can, in principle, integrate several independent molecular signals to widen the reliable PMI range.

Reality

Standardized protocols, cross-laboratory reproducibility and large-scale independent validation are still described in the literature as necessary next steps, not as completed milestones.

Could Molecular PMI Estimation Work in India?

Indian forensic medicine and forensic science departments are active contributors to this literature rather than passive observers of it. A 2023 study published in Science & Justice, conducted on road traffic accident cases — a scenario of major relevance to Indian forensic caseloads — examined miRNA-195, miRNA-206 and miRNA-378 as candidate markers for late PMI estimation, drawing on human casework rather than an animal model. This kind of applied, human-sample research is exactly the category of evidence that molecular PMI estimation needs more of, globally and specifically in the Indian context, where climate variability across regions (from Himalayan cold to peninsular heat and monsoon humidity) adds an additional layer of complexity beyond what temperate-climate studies typically model.

Beyond this, Indian and India-based authors appear as contributors across several of the broader systematic reviews cited in this article, including work on RNA stability and molecular PMI techniques. That said, this article does not claim that Indian forensic laboratories currently use RNA, protein, metabolomic, microbiome or multi-omics methods as a routine part of casework; no source reviewed here supports that claim, and it should not be assumed. What the evidence does support is that Indian medico-legal institutions, including forensic medicine departments at government medical colleges and forensic science universities, are positioned to contribute meaningfully to this research area — both because of the case volume many Indian mortuaries handle and because India's climatic diversity offers a natural testbed for questions this field still has not resolved, particularly around temperature and environmental variability.

What Would a Future Forensic Molecular Clock Need?

Drawing on how the reviewed literature evaluates candidate biomarkers, a genuinely forensic-ready molecular clock would need to demonstrate, at minimum:

1. Measurable, quantifiable change over the relevant PMI range
2. Reproducibility across independent laboratories and instruments
3. A clear, biologically understood mechanism driving the change
4. Limited sensitivity to environmental variables such as temperature and humidity
5. Low variability between individuals of different ages, health status and body composition
6. Reliable, standardized laboratory measurement protocols
7. A validated statistical or machine learning model relating the biomarker to elapsed time
8. Independent external validation on data the model was not trained on
9. A quantified, disclosed margin of uncertainty rather than a single point estimate
10. Demonstrated applicability to real forensic casework, not only animal models or small pilot cohorts

This list functions as an analytical framework for evaluating candidate biomarkers as they emerge, not as a description of an existing, formally adopted standard. Judged against it, most molecular PMI approaches currently satisfy the first three or four criteria and are actively working toward the rest.

What Researchers Should Watch Next

Several trends recur across the most recent (2025–2026) literature and are worth tracking. Multi-omics integration is clearly the direction the field is moving, with dedicated comprehensive reviews now appearing specifically on that topic. Machine learning is increasingly paired with metabolomic and proteomic data to model the nonlinear relationship between environmental temperature and degradation rate, rather than treating temperature as a nuisance variable to control away. Bone and hard-tissue proteomics is emerging as a particularly promising route for extending molecular methods into long PMI ranges where soft-tissue biomarkers have already been lost. And systematic reviews are increasingly explicit about the need for standardized protocols and independent, cross-population validation before any of these approaches can move from research literature into casework or courtroom use.

So, Can Molecular Changes After Death Become a Forensic Clock?

Based on the evidence reviewed here, the honest answer is neither a flat yes nor a flat no — it is a graded one, and the grading differs by molecule class.

Already establishedTraditional physical and biochemical methods (algor, rigor, livor mortis, decomposition staging, entomology) remain the backbone of practical PMI estimation, particularly in the first days after death.

PromisingRNA and microRNA degradation, and short-term protein degradation in soft tissue, all show measurable, biologically plausible correlations with PMI, backed by multiple systematic reviews, though not yet standardized for casework use.

EmergingBone and hard-tissue proteomics for long PMI, and metabolomics paired with machine learning for temperature-adjusted estimation, are advancing quickly but still rest on a comparatively narrow published evidence base.

ExperimentalMicrobiome-based "microbial clock" estimation and postmortem DNA methylation-based PMI (distinct from the well-validated age-estimation use of methylation) remain largely dependent on animal models, with human validation still limited.

Future possibilityA fully integrated, AI-driven multi-omics PMI model — combining several molecular layers with environmental and case-context data into a single estimate with a disclosed margin of error — is a coherent and actively pursued research direction, but it does not yet exist as a validated, deployable forensic tool.

Researchers are, in short, investigating whether predictable molecular changes after death can provide additional information about the postmortem interval — and the evidence so far suggests real potential, particularly as a complement to, rather than a replacement for, the traditional forensic toolkit. Substantial validation, standardization and cross-population testing remain necessary before that potential becomes routine forensic practice.

FAQs

Can molecular changes estimate time since death?

They can, in research settings, correlate with time since death, but no molecular method currently offers standalone, courtroom-ready precision. They are best understood as a developing complement to traditional PMI methods.

What is a forensic molecular clock?

It is a research concept describing the use of measurable postmortem molecular changes — in RNA, protein, metabolites, lipids, DNA methylation or microbial communities — as a proxy for elapsed time since death.

What biomarkers can estimate postmortem interval?

Reviewed candidates include RNA reference genes, microRNAs, structural and functional proteins, bone proteins, metabolites, lipids, DNA methylation markers, and postmortem microbial community composition.

Can RNA determine time since death?

RNA degradation correlates with PMI, especially in the early postmortem period, but degradation rates vary by tissue, gene and temperature, which limits current standalone use.

Can proteins determine time since death?

Specific proteins show consistent, measurable degradation patterns after death, particularly in skeletal muscle (short PMI) and bone (long PMI), but no single protein functions as a universal chronometer.

Can DNA degradation estimate PMI?

DNA fragments progressively after death and is especially useful for very late PMI in skeletal remains, but its degradation rate depends heavily on recovery environment and is not precise enough alone.

What is the microbial clock in forensic science?

It refers to the broadly time-ordered succession of microbial communities on and within a decomposing body, first described and popularized through animal-model research, now under active investigation as a potential PMI tool.

Can microbiome analysis estimate time since death?

Microbiome succession shows measurable, broadly predictable patterns, mainly demonstrated in animal cadaver models, with human validation and standardization still limited.

Can AI estimate postmortem interval?

Machine learning is increasingly used to combine multiple molecular and environmental variables into PMI prediction models, but current models are constrained by small datasets and limited external validation.

What is molecular PMI estimation?

It is the broad research field applying molecular biology techniques — genomics, transcriptomics, proteomics, metabolomics, lipidomics, epigenomics and microbiomics — to estimate elapsed time since death.

What is multi-omics in forensic science?

Multi-omics refers to combining several of these molecular data layers into a single, integrated model, on the reasoning that different molecules degrade at different rates and combining them may improve overall PMI accuracy.

How accurate is time-since-death estimation?

Accuracy is highest in the first 24–48 hours using traditional methods and declines substantially thereafter; molecular and multi-omics methods aim to extend reliable estimation further but have not yet been validated at the scale needed for routine, quantified accuracy claims.

References

1. He T, Song B, Fu J. Molecular biology research progress in post-mortem interval (PMI) estimation in forensic medicine. International Journal of Legal Medicine. 2026;140(1):13–28. https://doi.org/10.1007/s00414-025-03625-9
2. Zar MS, Bibi A, Akhtar MS. Unravelling time after death: A comprehensive review of multi-omics approaches in postmortem interval estimation. Forensic Science International. 2026;379:112779. https://doi.org/10.1016/j.forsciint.2025.112779
3. Cianci V, Fracasso T, Germanà A, et al. Forensic applications of postmortem protein analysis in estimating the time since death: a systematic review. International Journal of Legal Medicine. 2026;140(3):1665–1688. https://doi.org/10.1007/s00414-026-03730-3
4. Mróz M, Miodońska M, Cieśla J, Skowronek R, Tomsia M. As precisely as possible! Molecular methods of postmortem interval prediction – current prospects and limitations. Journal of Forensic and Legal Medicine. 2025;115:102946. https://doi.org/10.1016/j.jflm.2025.102946
5. Postmortem microbiome dynamics: Review of forensic microbial clock. Journal of Forensic and Legal Medicine. 2026;117:103024. https://doi.org/10.1016/j.jflm.2025.103024
6. Secco L, Palumbi S, Padalino P, Grosso E, Perilli M, Casonato M, Cecchetto G, Viel G. "Omics" and Postmortem Interval Estimation: A Systematic Review. International Journal of Molecular Sciences. 2025;26(3):1034. https://doi.org/10.3390/ijms26031034
7. Thakral S, Purohit P, Mishra R, Gupta V, Setia P. The impact of RNA stability and degradation in different tissues to the determination of post-mortem interval: A systematic review. Forensic Science International. 2023;349:111772. https://doi.org/10.1016/j.forsciint.2023.111772
8. Pasaribu RS, Auerkari EI, Suhartono AW, Auerkari P. A small RNA, microRNA as a potential biomolecular marker to estimate post mortem interval in forensic science: a systematic review. International Journal of Legal Medicine. 2023;137:1313–1325. https://doi.org/10.1007/s00414-023-03015-z
9. Cianci V, Mondello C, Sapienza D, Guerrera MC, Cianci A, Cracò A, Luppino F, Gioffrè V, Gualniera P, Asmundo A, et al. microRNAs as New Biomolecular Markers to Estimate Time since Death: A Systematic Review. International Journal of Molecular Sciences. 2024;25:9207. https://doi.org/10.3390/ijms25179207
10. Gupta T, Devi V, Rao A, et al. Molecular forensics: RNA degradation as a marker for postmortem interval determination. International Journal of Legal Medicine. 2026;140:1735–1747. https://doi.org/10.1007/s00414-025-03702-z
11. Sangwan A, Singh SP, Singh P, et al. Role of molecular techniques in PMI estimation: an update. Journal of Forensic and Legal Medicine. 2021;83:102251. https://doi.org/10.1016/j.jflm.2021.102251
12. Chhikara A, Kumari P, Dalal J, et al. Protein degradation patterns as biomarkers for post-mortem interval estimation: A comprehensive review of proteomic approaches in forensic science. Journal of Proteomics. 2025;310:105326. https://doi.org/10.1016/j.jprot.2025.105326
13. Sharma R, Diksha, Bhute AR, et al. Application of artificial intelligence and machine learning technology for the prediction of postmortem interval: A systematic review of preclinical and clinical studies. Forensic Science International. 2022;340:111473. https://doi.org/10.1016/j.forsciint.2022.111473
14. Singh P, Ali W, Sandhu S, Mishra S, Singh US, Verma AK, Singh M, Ahmad MK, Kumari S. Post-mortem interval estimation using miRNAs of road traffic accident cases: A forensic molecular approach. Science & Justice. 2023;63(4):485–492. https://doi.org/10.1016/j.scijus.2023.04.011
15. Badell J, et al. DNA methylation and epigenomic profiling post-mortem of human remain analogs (Sus scrofa) in southern Ontario, Canada. Journal of Forensic Sciences. 2026. https://doi.org/10.1111/1556-4029.70304
16. Zhao X, Yang F, et al. Seasonal mouse cadaver microbial study: rupture time and postmortem interval estimation model construction. PeerJ. 2024;12:e17932.
17. Current Understanding and Future Research Direction for Estimating the Postmortem Interval: A Systematic Review. Diagnostics. 2025;15(15):1954. https://doi.org/10.3390/diagnostics15151954
18. Choi K-M, Zissler A, Kim E, Ehrenfellner B, Cho E, Lee S, Steinbacher P, Yun KN, Shin JH, Kim JY, Stoiber W, Chung H, Monticelli FC, Kim J-Y, Pittner S. Postmortem proteomics to discover biomarkers for forensic PMI estimation. International Journal of Legal Medicine. 2019;133(3):899–908. https://doi.org/10.1007/s00414-019-02011-6
19. Proteomic profiling of bone for the estimation of post-mortem interval and post-mortem submersion interval: a systematic review. International Journal of Legal Medicine. 2026. https://doi.org/10.1007/s00414-026-03844-8
20. Postmortem age estimation via DNA methylation analysis in buccal swabs from corpses in different stages of decomposition — a "proof of principle" study. International Journal of Legal Medicine.
21. Using the postmortem epinecrotic microbiome as a tool for time since death estimations. Journal of Applied Microbiology. 2025;136(11):lxaf274.

This article synthesizes peer-reviewed forensic literature published primarily between 2023 and 2026, with priority given to 2025–2026 systematic reviews. Findings from animal-model studies are identified as such throughout and should not be read as established human forensic practice. Where evidence is preliminary, mixed, or limited to small cohorts, this is stated explicitly rather than implied.